Company intelligence / Profile preview

Bio-Strategy

Ownership: Private
Employees: ~130
Development stage: Commercial

Overview

Bio‑Strategy is an ISO9001-accredited distributor of scientific instrumentation, laboratory equipment, consumables, chemicals and reagents for research and clinical diagnostics. The company serves the life sciences sector—including academic research labs, diagnostic laboratories, government institutes and industry—across Australia, New Zealand and the South Pacific. In 2023 it became part of DKSH Group. It partners with leading global suppliers to provide technology solutions for genomics, proteomics, molecular biology and more.

Industry: Chemicals & Materials

Partnerships

Biosero (distribution partnership)

Beyond the preview

Go deeper on Bio-Strategy.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Bio-Strategy.

Explore the full profile